Literature DB >> 959970

Kinin activation in the blood of patients with sepsis.

T F O'Donnell, G H Clowes, R C Talamo, R W Colman.   

Abstract

To determine whether or not kinin activation in the blood during severe infection with gram-negative bacteria may be related to hemodynamic abnormalities encountered, blood prekallikrein, kallikrein inhibitor and kinin values in 2l surgical patients with sepsis were compared with those in normotensive and hypotensive states. Because of reduced prekallikrein synthesis in patients with hepatic insufficiency, the normotensive and hypotensive groups were each subdivided according to the presence or absence of liver dysfunction, as indicated by elevated blood bilirubin, serum glutamic-oxalacetic transaminase or alkaline phosphatase levels. The mortality was zero in group 1, normotensive normal liver function; 80 per cent in group 2, hypotensive-normal liver function; 20 per cent in group 3, normotensive liver dysfunction, and 67 per cent in group 4, hypotensive liver dysfunction. Ultimately, the majority of deaths were due to respiratory failure. Although the blood prekallikrein level, was below normal in all groups and was significantly less in all patients with liver dysfunction, it was reduced proportionately in hypotensive patients to less than 30 per cent of the values noted in the two normotensive groups. This finding suggests prekallikrein consumption in the hypotensive groups to be the result of the process of activating kallikrein and bradykinin. This concept is supported by finding elevated kinin values, above 3 nanograms per milliliter of plasma, in only 28 per cent of those in group 1 and 12 per cent of those in group 3, while in the hypotensive patients, groups 2 and 4, the kinin level was elevated in 60 and 66 per cent, respectively.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 959970

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  12 in total

1.  Recombinant alpha 1-antitrypsin Pittsburgh attenuates experimental gram-negative septicemia.

Authors:  R W Colman; D N Flores; R A De La Cadena; C F Scott; L Cousens; P J Barr; I B Hoffman; F Kueppers; D Fisher; S Idell
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

Review 2.  Overview: pharmacology of ticlopidine.

Authors:  J L Gordon
Journal:  Agents Actions Suppl       Date:  1984

3.  The plasma kallikrein kinin system in severely ill and traumatised patients.

Authors:  A D Cumming; C E Robertson; S S Jeffrey; J S Robson; I M Ledingham
Journal:  Arch Emerg Med       Date:  1984-09

4.  Staphylococcus aureus induces release of bradykinin in human plasma.

Authors:  E Mattsson; H Herwald; H Cramer; K Persson; U Sjöbring; L Björck
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

5.  Proteolytic inactivation of plasma C1- inhibitor in sepsis.

Authors:  J H Nuijens; A J Eerenberg-Belmer; C C Huijbregts; W O Schreuder; R J Felt-Bersma; J J Abbink; L G Thijs; C E Hack
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

6.  Activation of the contact system in lethal hypotensive bacteremia in a baboon model.

Authors:  R A Pixley; R A DeLa Cadena; J D Page; N Kaufman; E G Wyshock; R W Colman; A Chang; F B Taylor
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

7.  The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons.

Authors:  R A Pixley; R De La Cadena; J D Page; N Kaufman; E G Wyshock; A Chang; F B Taylor; R W Colman
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

8.  Plasma kallikrein activation and inhibition during typhoid fever.

Authors:  R W Colman; R Edelman; C F Scott; R H Gilman
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

9.  The effects of Escherichia coli bacteremia on in vitro perfused kidneys.

Authors:  L J Auguste; A M Stone; L Wise
Journal:  Ann Surg       Date:  1980-07       Impact factor: 12.969

Review 10.  Metabolic basis for management of the septic surgical patient.

Authors:  J H Shaw; J B Koea
Journal:  World J Surg       Date:  1993 Mar-Apr       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.